Published in Gut on April 01, 1994
Effects of fat and carbohydrate meals on colonic motor response. Gut (2000) 1.54
An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut (2001) 1.26
Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut (1995) 1.25
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol (2008) 1.09
Pharmacology of serotonin: what a clinician should know. Gut (2004) 1.02
Serotonergic modulation of visceral sensation: lower gut. Gut (2002) 1.00
Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil (2007) 0.92
Differential regional effects of octreotide on human gastrointestinal motor function. Gut (1995) 0.90
Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol (2013) 0.88
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut (1998) 0.88
Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2009) 0.87
Hyperventilation, central autonomic control, and colonic tone in humans. Gut (1995) 0.86
Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients. Gut (2006) 0.84
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci (2010) 0.84
Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Am J Physiol Gastrointest Liver Physiol (2011) 0.82
Relationship between postprandial metabolomics and colon motility in children with constipation. Neurogastroenterol Motil (2013) 0.82
Gastrointestinal motility after digestive surgery. Surg Today (2007) 0.81
Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut (1997) 0.81
Gastrointestinal endocrine cells in an animal model for human type 2 diabetes. Dig Dis Sci (1999) 0.80
Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial. Br J Clin Pharmacol (2000) 0.78
Novel therapeutic agents in neurogastroenterology: advances in the past year. Neurogastroenterol Motil (2014) 0.77
Is the colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain? Dig Dis Sci (2011) 0.76
Of actors, bolting horses, and drops in oceans! Gut (2003) 0.76
Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs. World J Gastroenterol (2013) 0.76
Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Dig Liver Dis (2013) 0.75
Pharmacologic Agents for Chronic Diarrhea. Intest Res (2015) 0.75
Postoperative colonic motility after tropisetron and a standardized meal in patients undergoing conventional colorectal surgery. Int J Colorectal Dis (2006) 0.75
Lack of an Effect of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response. Dig Dis Sci (2017) 0.75
Comparison of ileoanal pouch and rectal function measured by barostat. Dig Dis Sci (2001) 0.75
Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. I. Resting patterns of motility. Gastroenterology (1961) 3.78
Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med (1990) 3.05
The differential effect of drugs on the proximal and distal colon. Am J Med (1960) 2.80
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol (1989) 2.31
Physiological variations in canine gastric tone measured by an electronic barostat. Am J Physiol (1985) 2.01
Comparison of the effect of meals and prostigmine on the proximal and distal colon in patients with and without diarrhoea. Gut (1966) 1.89
Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. N Engl J Med (1978) 1.71
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology (1978) 1.52
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med (1993) 1.45
The concept of selectivity in 5-HT receptor research. Eur J Pharmacol (1990) 1.32
Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action. Pharmacol Res (1991) 1.28
Variation of muscle tone in the human colon. Gastroenterology (1991) 1.22
GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci (1990) 1.20
Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology (1992) 1.20
Role of cholecystokinin in the gastrocolonic response to a fat meal. Gastroenterology (1983) 1.07
Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther (1990) 1.05
Control of muscle tone in the human colon. Gut (1992) 0.98
Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction. J Pharmacol Exp Ther (1990) 0.94
Measurement of tone in canine colon. Am J Physiol (1991) 0.88
Vagal influence on colonic motor activity in conscious nonhuman primates. Am J Physiol (1992) 0.88
Colonic motor response to eating: a manometric investigation in proximal and distal portions of the viscus in man. Am J Gastroenterol (1989) 0.87
Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut (1993) 0.83
Right and left colonic transit after eating assessed by a dual isotopic technique in healthy humans. Gastroenterology (1992) 0.83
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
Fending off furtive strategists. Science (1999) 2.65
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther (2002) 2.37
Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil (2004) 2.28
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology (1991) 1.98
Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol (2000) 1.93
Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol (1990) 1.90
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res (2001) 1.84
Comparison of methods for measurement of bacterial growth rates in mixed batch cultures. Appl Environ Microbiol (1982) 1.83
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81
Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology (1997) 1.80
Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology (1986) 1.79
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology (2000) 1.74
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil (2011) 1.72
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology (1991) 1.63
Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil (2004) 1.63
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med (2000) 1.61
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil (2005) 1.60
[13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology (1997) 1.59
Adrenergic modulation of human colonic motor and sensory function. Am J Physiol (1997) 1.59
Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest (1984) 1.59
Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc (1995) 1.58
Development of a test to measure gastric accommodation in humans. Am J Physiol (1999) 1.56
Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med (1997) 1.54
Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut (2003) 1.53
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51
Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil (2009) 1.51
The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology (1995) 1.50
Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology (1986) 1.49
Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol (1992) 1.48
Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology (1994) 1.47
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut (2008) 1.47
Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc (1992) 1.46
Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology (1995) 1.46
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology (2000) 1.45
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med (1993) 1.45
Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology (1999) 1.42
Gastrointestinal manifestations of systemic vasculitis. Q J Med (1983) 1.41
Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology (1992) 1.41
Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil (2004) 1.40
Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil (2003) 1.39
Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol (2001) 1.36
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil (2009) 1.35
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association. Gastroenterology (1999) 1.32
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut (1999) 1.31
Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol (1995) 1.30
Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol (1999) 1.30
Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2001) 1.29
Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil (2009) 1.29
Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol (2001) 1.28
Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut (1995) 1.25
Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol (1998) 1.24
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol (2001) 1.23
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol (1998) 1.22
Variation of muscle tone in the human colon. Gastroenterology (1991) 1.22
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil (2004) 1.19
Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology (1990) 1.19
Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 1.18
Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology (1987) 1.18
Fluctuations of lactoferrin protein and messenger ribonucleic acid in the reproductive tract of the mouse during the estrous cycle. Biol Reprod (1992) 1.18
Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol (2000) 1.18
Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci (1986) 1.18
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol (1993) 1.15
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil (2006) 1.15
Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis (2000) 1.15
A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology (1994) 1.14
Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst (1994) 1.14
Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology (1991) 1.14
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med (1995) 1.13
Mechanisms in IBS: something old, something new, something borrowed... Neurogastroenterol Motil (2005) 1.13
Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil (2005) 1.13
Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology (1995) 1.13
Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc (1989) 1.13
A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut (2000) 1.11